Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension

By Lee J-M   Kim J-H   Son H-S   Hong E-G   Yu J-M   Han K-A   Min K-W   Chang S-A  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 234-241

Field House Publishing

Access to resources Recommend Favorite

The use of fibric acid derivatives combined with rosiglitazone appears to decrease HDL cholesterol levels in patients with diabetes mellitus (DM)

By  

Reactions Weekly, Vol. 1, Iss. 1184, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension: A Retrospective Study

By Hamamoto Yoshiyuki   Honjo Sachiko   Kawasaki Yukiko   Ikeda Hiroki   Mori Kanako   Fujimoto Kanta   Tatsuoka Hisato   Iwasaki Yorihiro   Nomura Kazuhiro   Wada Yoshiharu   Koshiyama Hiroki  

Clinical Drug Investigation, Vol. 32, Iss. 9, 2012-09 ,pp. : 577-582

Adis International

Access to resources Recommend Favorite

Relationship between Fasting and 2-hour Postprandial Plasma Glucose Levels and Vascular Complications in Patients with Type 2 Diabetes Mellitus

By Tanaka M  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1295-1303

Field House Publishing

Access to resources Recommend Favorite

The Evil Axis of Obesity, Inflammation and Type-2 Diabetes

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 23-31

Bentham Science Publishers

Access to resources Recommend Favorite